PINK:CLYYF

Celyad Oncology Sa Stock Forecast

etoro logo Buy CLYYF
*Your capital is at risk
$0.200
+0 (+0%)
At Close: Aug 10, 2026

Should you buy CLYYF stock?

Last updated:

Based on market data through , StockInvest.us rates Celyad Oncology Sa (CLYYF) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Hold signal since
  • Price since signal Flat 0.00%
  • 3-month trend forecast Down 22.88%
  • Hold/Accumulate 0.00
AI Analysis AI Analysis of CLYYF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CLYYF to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Monday for Celyad Oncology Sa
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jul 28, 2026

No changes to the price of Celyad Oncology Sa stock on the last trading day (Monday, 10th Aug 2026). During the last trading day the stock fluctuated 0% from a day low at $0.200 to a day high of $0.200. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -22.88% during the next 3 months and, with a 90% probability hold a price between $0.137 and $0.174 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CLYYF Signals & Forecast

There are mixed signals in the stock today. The Celyad Oncology Sa stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.200 and $0.219. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Friday, July 10, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Celyad Oncology Sa stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $0.188 (-6.00%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 21 days ago.)

Trading Expectations (CLYYF) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Celyad Oncology Sa to open at $0.200, and during the day (based on 14 day Average True Range), to move between $0.179 and $0.221, which gives a possible trading interval of +/-$0.0421 (+/-23.52%) up or down from last closing price. If Celyad Oncology Sa takes out the full calculated possible swing range there will be an estimated 23.52% move between the lowest and the highest trading price during the day.

Is Celyad Oncology Sa stock A Buy?

Celyad Oncology Sa holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $0.200 ( 0.00000000000001%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CLYYF Performance

Trading levels for CLYYF

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.200 0.00000000000001%
R2 0.200 0.00000000000001%
R1 0.200 0.00000000000001%
Price 0.200
S1 0.200 0.00000000000001%
S2 0.200 0.00000000000001%
S3 0.200 0.00000000000001%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 0.200
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Celyad Oncology Sa Stock and on which exchange is it traded?
The symbol for Celyad Oncology Sa is CLYYF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Celyad Oncology Sa Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Celyad Oncology Sa (CLYYF) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Jul 28, 2026, the price has remained flat. The current 3-month trend forecast projects a fall of 22.88%.

How to buy Celyad Oncology Sa Stock?
Celyad Oncology Sa Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Celyad Oncology Sa Stock.

What's the current price of Celyad Oncology Sa Stock?
As of the end of day on the Aug 10, 2026, the price of an Celyad Oncology Sa (CLYYF) share was $0.200.

What is the 52-week high and low for Celyad Oncology Sa Stock?
The 52-week high for Celyad Oncology Sa Stock is $0.530 and the 52-week low is $0.150.

What is the market capitalization of Celyad Oncology Sa Stock?
As of the Aug 10, 2026, the market capitalization of Celyad Oncology Sa is 12.533M.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE